Cargando…

Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma

There are health concerns associated with increased folic acid intake from fortified food and supplements. Existing analytical methods, however, which can be employed to carry out epidemiological and bioavailability studies for folic acid involve laborious sample preparation and/or lengthy chromatog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayed, Aref, Bustami, Rana, Alabsi, Wafaa, El-Elimat, Tamam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027057/
https://www.ncbi.nlm.nih.gov/pubmed/29861484
http://dx.doi.org/10.3390/ph11020052
_version_ 1783336533813624832
author Zayed, Aref
Bustami, Rana
Alabsi, Wafaa
El-Elimat, Tamam
author_facet Zayed, Aref
Bustami, Rana
Alabsi, Wafaa
El-Elimat, Tamam
author_sort Zayed, Aref
collection PubMed
description There are health concerns associated with increased folic acid intake from fortified food and supplements. Existing analytical methods, however, which can be employed to carry out epidemiological and bioavailability studies for folic acid involve laborious sample preparation and/or lengthy chromatographic analysis. In this paper we describe a simple, rapid, and sensitive high-performance liquid chromatography–electrospray ionisation-tandem mass spectrometry (HPLC–ESI-MS/MS) method for determination of unmetabolised folic acid in human plasma using folic acid-d4 as an internal standard. The method required only a simple sample preparation step of protein precipitation and had a total run time of 3.5 min, which is the shortest run time reported to date for HPLC–MS/MS method employed for quantifying folic acid in plasma. The analytes were separated on a C18 column (3 µm; 50 × 3.00 mm) using an isocratic mobile phase consisting of ammonium acetate (1 mM)-acetic acid-acetonitrile (9.9:0.1:90, v/v/v). The method was fully validated in terms of accuracy, precision, linearity, selectivity, recovery, matrix effect, and stability. The short run time and the minimal sample preparation makes the method a valuable tool for performing high-throughput analyses. To demonstrate the applicability of the method in real conditions, it was applied successfully in a bioavailability study for the determination of unmetabolised folic acid levels in vivo in human plasma after oral administration of folic acid.
format Online
Article
Text
id pubmed-6027057
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60270572018-07-13 Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma Zayed, Aref Bustami, Rana Alabsi, Wafaa El-Elimat, Tamam Pharmaceuticals (Basel) Article There are health concerns associated with increased folic acid intake from fortified food and supplements. Existing analytical methods, however, which can be employed to carry out epidemiological and bioavailability studies for folic acid involve laborious sample preparation and/or lengthy chromatographic analysis. In this paper we describe a simple, rapid, and sensitive high-performance liquid chromatography–electrospray ionisation-tandem mass spectrometry (HPLC–ESI-MS/MS) method for determination of unmetabolised folic acid in human plasma using folic acid-d4 as an internal standard. The method required only a simple sample preparation step of protein precipitation and had a total run time of 3.5 min, which is the shortest run time reported to date for HPLC–MS/MS method employed for quantifying folic acid in plasma. The analytes were separated on a C18 column (3 µm; 50 × 3.00 mm) using an isocratic mobile phase consisting of ammonium acetate (1 mM)-acetic acid-acetonitrile (9.9:0.1:90, v/v/v). The method was fully validated in terms of accuracy, precision, linearity, selectivity, recovery, matrix effect, and stability. The short run time and the minimal sample preparation makes the method a valuable tool for performing high-throughput analyses. To demonstrate the applicability of the method in real conditions, it was applied successfully in a bioavailability study for the determination of unmetabolised folic acid levels in vivo in human plasma after oral administration of folic acid. MDPI 2018-05-27 /pmc/articles/PMC6027057/ /pubmed/29861484 http://dx.doi.org/10.3390/ph11020052 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zayed, Aref
Bustami, Rana
Alabsi, Wafaa
El-Elimat, Tamam
Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
title Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
title_full Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
title_fullStr Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
title_full_unstemmed Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
title_short Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
title_sort development and validation of a rapid high-performance liquid chromatography–tandem mass spectrometric method for determination of folic acid in human plasma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027057/
https://www.ncbi.nlm.nih.gov/pubmed/29861484
http://dx.doi.org/10.3390/ph11020052
work_keys_str_mv AT zayedaref developmentandvalidationofarapidhighperformanceliquidchromatographytandemmassspectrometricmethodfordeterminationoffolicacidinhumanplasma
AT bustamirana developmentandvalidationofarapidhighperformanceliquidchromatographytandemmassspectrometricmethodfordeterminationoffolicacidinhumanplasma
AT alabsiwafaa developmentandvalidationofarapidhighperformanceliquidchromatographytandemmassspectrometricmethodfordeterminationoffolicacidinhumanplasma
AT elelimattamam developmentandvalidationofarapidhighperformanceliquidchromatographytandemmassspectrometricmethodfordeterminationoffolicacidinhumanplasma